Results 1 -
10
of
160
for
pembrolizumab
- FDA has approved the immunotherapy drug pembrolizumab (Keytruda®) for use in some patients with advanced gastric (stomach) cancer that is PD-L1 positive.
- Skin Cancer/Statistics and Research ... Skin Cancer ... Melanoma/Statistics and Research ... Melanoma ... National Cancer Institute ... From the National Institutes of Health ... Find ...
- ... clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with advanced ...
- Targeted Therapy - Immunotherapy Combinations Effective for Advanced Kidney Cancer
(National Cancer Institute)
Kidney Cancer/Statistics and Research ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... For patients with advanced kidney cancer, ... - Breast Cancer/Statistics and Research ... Breast Cancer ... Male Breast Cancer/Statistics and Research ... Male Breast Cancer ... National Cancer Institute ... This page highlights ...
- Skin Cancer/Treatments and Therapies ... Skin Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved by ...
- Bladder Cancer/Treatments and Therapies ... Bladder Cancer ... National Cancer Institute ... From the National Institutes of Health ... Learn how bladder cancer is treated, ...
- Renal cell cancer treatment options include surgery, radiation therapy, chemotherapy, biologic therapy, and targeted therapy. Learn more about the treatment ...
- Triple-Negative Breast Cancer (Living Beyond Breast Cancer)About 10% to 15% of breast cancers are triple-negative. Learn more about the symptoms, treatment options, and myths about TNBC. ... Breast Cancer/Specifics ...
- Melanoma/Start Here ... Melanoma ... Melanoma treatment options include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Learn more ...